Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines

Grant, E., Bucklain, F.A., Ginn, L. et al. (3 more authors) (2022) Progesterone receptor expression contributes to gemcitabine resistance at higher ECM stiffness in breast cancer cell lines. PLoS ONE, 17 (5). e0268300.

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2022 The Authors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited (http://creativecommons.org/licenses/by/4.0/).
Dates:
  • Accepted: 26 April 2022
  • Published (online): 26 May 2022
  • Published: 26 May 2022
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Science (Sheffield) > Department of Chemistry (Sheffield)
Funding Information:
FunderGrant number
Medical Research CouncilMR/K015753/1
European Commission - HORIZON 2020713475
Depositing User: Symplectic Sheffield
Date Deposited: 01 Jun 2022 09:13
Last Modified: 01 Jun 2022 09:13
Status: Published
Publisher: Public Library of Science (PLoS)
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pone.0268300
Related URLs:

Share / Export

Statistics